State Street Corp Rvl Pharmaceuticals PLC Transaction History

State Street Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.08 - $0.55 $2,224 - $15,290	27,800 Added 35.33%	106,487 $9,000
Q4 2022 Feb 14, 2023	BUY	$1.02 - $1.61 $6,630 - $10,465	6,500 Added 9.0%	78,687 $88,000
Q2 2022 Aug 15, 2022	BUY	$1.21 - $1.81 $40,417 - $60,459	33,403 Added 86.13%	72,187 $98,000
Q1 2022 May 16, 2022	BUY	$1.03 - $2.01 $4,738 - $9,245	4,600 Added 13.46%	38,784 $66,000
Q3 2021 Nov 15, 2021	BUY	$2.79 - $4.19 $10,881 - $16,341	3,900 Added 12.88%	34,184 $101,000
Q2 2021 Aug 16, 2021	SELL	$2.8 - $3.78 $499,573 - $674,423	-178,419 Reduced 85.49%	30,284 $91,000
Q1 2021 May 17, 2021	SELL	$3.26 - $4.84 $39,501 - $58,646	-12,117 Reduced 5.49%	208,703 $680,000
Q4 2020 Feb 16, 2021	BUY	$4.12 - $6.29 $18,750 - $28,625	4,551 Added 2.1%	220,820 $910,000
Q3 2020 Nov 10, 2020	BUY	$4.82 - $8.77 $171,948 - $312,860	35,674 Added 19.75%	216,269 $1.17 Million
Q2 2020 Aug 14, 2020	BUY	$2.83 - $6.99 $46,058 - $113,762	16,275 Added 9.9%	180,595 $1.22 Million
Q1 2020 May 11, 2020	BUY	$3.18 - $7.0 $522,537 - $1.15 Million	164,320 New	164,320 $523,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.